Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENG block with liposomal bupivacaine after total hip arthroplasty
ChiCTR2300076780Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoints: Visual Analog Scale (VAS) scores and Quality of recovery-15 scale (QoR-15). Started Oct 2023; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300076780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076780.